FTY-720 is efficacious in monkey kidney transplantation.
Quesniaux
V
V
Department of Transplantation, Preclinical Research, Novartis Pharma AG, Basel, Switzerland.
Menninger
K
K
Audet
M
M
Gaschen
L
L
Schuurman
H J
HJ
D000017:ABO Blood-Group System / Q000276:immunology; D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D000068338:Everolimus; D000068876:Fingolimod Hydrochloride; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006650:Histocompatibility Testing; D016130:Immunophenotyping; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008252:Macaca fascicularis; D008285:Major Histocompatibility Complex; D011409:Propylene Glycols / Q000627:therapeutic use*; D020123:Sirolimus / Q000031:analogs & derivatives / Q000627:therapeutic use; D013110:Sphingosine / Q000031:analogs & derivatives; D013601:T-Lymphocytes / Q000276:immunology; D013997:Time Factors
D000017:ABO Blood-Group System; D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D016572:Cyclosporine; D000068338:Everolimus; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D020123:Sirolimus